Registro:

Referencias:

• Abe, K., Yoshida, M., Usui, T., Horinouchi, S., Beppu, T., Highly synchronous culture of fibroblast from G2 block caused by staurosporine, a potent inhibitor of protein kinases (1991) Exp. Cell Res., 192, pp. 122-127
• Akiyama, T., Ogawara, H., Use and specificity of genistein as inhibitor of protein-tyrosine kinase (1991) Methods Enzymol., 201, pp. 362-370
• Altman, J., Das, G.D., Autoradiographic and histopathological studies of postnatal neurogenesis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions (1966) J. Comp. Neurol., 126, pp. 337-390
• Azuma, Y., Onishi, Y., Sato, Y., Kizaki, H., Effects of protein tyrosine kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2-dependent CTLL-2 cells (1995) J. Biochem., 118, pp. 312-318
• Bare, D.J., Ghetti, B., Richter, J.A., The tyrosine kinase inhibitor genistein increases endogenous dopamine release from normal and weaver mutant mouse striatal slices (1995) J. Neurochem., 65, pp. 2096-2114
• Barnes, S., Effects of genistein on in vitro and in vivo models of cancer (1995) J. Nutr., 125, pp. 777S-783S
• Boulikas, T., Control of DNA replication by protein phosphorylation (1994) Anticancer Res., 14, pp. 2465-2472
• Boulikas, T., Phosphorylation of transcription factors and control of the cell cycle (1995) Crit. Rev. Eukaryot. Gene Express., 5, pp. 1-77
• Chajry, N., Martin, P.-M., Pages, G., Cochet, C., Afdel, K., Berthois, Y., Relationship between MAP kinase activity and the dual effect of EGF on A431 cell proliferation (1994) Biochem. Biophys. Res. Commun., 203, pp. 984-990
• Chen, P., Xie, H., Wells, A., Mitogenic signalling from the EGF receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism (1996) Mol. Biol. Cell, 7, pp. 871-881
• Clark, J.W., Santos-Moore, A., Stevenson, L.E., Frackleton R., Jr., Effect of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signalling pathway (1996) Int. J. Cancer, 65, pp. 186-191
• Cotton, P.C., Brugge, J.S., Neural tissue express high levels of the cellular src gene product pp60c-src (1983) Mol. Cell. Biol., 3, pp. 1157-1162
• Cripps-Wolfman, J., Henshaw, E.C., Bambara, R.A., Alterations in the phosphorylation and activity of DNA polymerase a correlate with the change in replicative DNA synthesis as quiescent cells re-enter the cell cycle (1989) J. Biol. Chem., 264, pp. 19478-19486
• Crissman, H.A., Gadbois, D.M., Tobey, R.A., Bradbury, E.M., Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 7580-7584
• Cudmore, S.B., Gurd, J.W., Postnatal age and protein tyrosine phosphorylation at synapses in the developing rat brain (1991) J. Neurochem., 57, pp. 1240-1248
• Das, M., Initiation of nuclear DNA replication: Evidence for formation of commited prereplicative cellular state (1981) Proc. Natl. Acad. Sci. USA, 78, pp. 5677-5681
• Dasgupta, J.D., Swarup, G., Garbers, D.L., Tyrosine protein kinase activity in normal rat and brain tissue (1984) Adv. Cyclic. Nucleotide Protein Phosphorylation Res., 17, pp. 461-470
• Dasso, M., Smythe, C., Milarski, K., Kornbluth, S., Newport, J.W., DNA replication and progression through the cell cycle (1992) Ciba Found. Symp., pp. 161-180
• Doree, M., Galas, S., The cyclin-dependent protein kinases and the control of cell division (1994) FASEB J., 8, pp. 1114-1121
• Dunphy, W.G., Kumagai, A., The cdc25 protein contains an intrinsec phosphatase activity (1991) Cell, 67, pp. 189-196
• Fallon, R.J., Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes (1990) Biochem. Biophys. Res. Commun., 170, pp. 1191-1196
• Fu, X.W., A transcription factor with SH2 and SH3 domains is directly activated by an interferon a-induced cytoplasmic protein tyrosine kinase(s) (1992) Cell, 70, pp. 323-335
• Fujita-Yamaguchi, Y., Kathuria, S., Characterization of receptor tyrosine-specific kinases by the use of inhibitors: Staurosporine is 100-times more potent inhibitor of insulin receptor than IGF-I receptor (1988) Biochem. Biophys. Res. Commun., 157, pp. 955-962
• Gadbois, D.M., Hamaguchi, J.R., Swank, R.A., Bradbury, E.M., Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases (1992) Biochem. Biophys. Res. Commun., 184, pp. 80-85
• Gamou, S., Shimizu, N., Calphostin-C stimulates epidermal growth factor receptor phosphorylation and internalization via light-dependent mechanism (1994) J. Cell. Physiol., 158, pp. 151-159
• Gautier, J., Solomon, M.J., Booher, R.N., Fernando Bazan, J., Kirschner, M.W., Cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2 (1991) Cell, 67, pp. 197-211
• Gomez-Lechon, M.J., Guillen, I., Ponsoda, X., Fabra, R., Trullenque, R., Nakamura, T., Castell, J.V., Cell cycle progression proteins (cyclins), oncogene expression, and signal transduction during the proliferative response of human hepatocytes to hepatocyte growth factor (1996) Hepatology, 23, pp. 1012-1019
• Gordon, J.A., Use of vanadate as protein-phosphotyrosine phosphatase inhibitor (1991) Methods Enzymol., 201, pp. 477-482
• Gutch, M.J., Daly, C., Reich, N.C., Tyrosine phosphorylation is required for activation of a a interferon-stimulated transcription factor (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 11411-11415
• Hall, L.L., Th'Ng, J.P., Guo, X.W., Teplitz, R.L., Bradbury, E.M., A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation (1996) Cancer Res., 56, pp. 3551-3559
• Hofmann, J., The potential for isozyme-selective modulation of protein kinase C (1997) FASEB J., 11, pp. 649-669
• Hu, B.R., Yang, Y.B.O., Wieloch, T., Depression of neuronal protein synthesis initiation by protein tyrosine kinase inhibitors (1993) J. Neurochem., 61, pp. 1789-1794
• Huang, J., Nasr, M., Kim, Y., Matthews, H.R., Genistein inhibits protein histidine kinase (1992) J. Biol. Chem., 267, pp. 15511-15515
• Isaacs, R.J., Davies, S.L., Sandri, M.I., Redwood, C., Wells, N.J., Hicson, I.D., Physiological regulation of eukaryotic topoisomerase II (1998) Biochim. Biophys. Acta, 1400, pp. 121-137
• Kim, H., Peterson, T.G., Barnes, S., Mechanism of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor b signalling pathways (1998) Am. J. Clin. Nutr., 68, pp. 1418S-1425S
• Kobayashi, E., Nakano, H., Morimoto, M., Tamaoki, T., Calphostin-C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C (1989) Biochem. Biophys. Res. Commun., 159, pp. 548-553
• Labarca, C., Paigen, K., A simple, rapid, and sensitive DNA assay procedure (1980) Anal. Biochem., 102, pp. 344-352
• Langan, T.J., Slater, M.C., Kelly, K., Novel relationships of growth factors to the G1/S transition in cultured astrocytes from rat forebrain (1994) Glia, 10, pp. 30-39
• Laskey, R.A., Fairman, M.P., Blow, J.J., S phase of the cell cycle (1989) Science, 246, pp. 609-614
• Lassota, P., Singh, G., Kramer, R., Mechanism of topoisomerase II inhibition by staurosporine and other protein kinase inhibitors (1996) J. Biol. Chem., 271, pp. 26418-26423
• Markovits, J., Linassier, C., Fosse, P., Couprie, J., Pierre, J., Jacquemin-Sablon, A., Saucier, J.-M., Larsen, A.K., Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II (1989) Cancer Res., 49, pp. 5111-5117
• McAbe, M.J., Orrenius, S., Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II (1993) Biochem. Biophys. Res. Commun., 194, pp. 944-950
• McAuley, A., Werb, Z., Mirkes, P.E., Characterization of the unusually rapid cell cycles during rat gastrulation (1993) Development, 117, pp. 873-883
• Medema, R.H., Klompmaker, R., Smits, V.A., Rijksen, G., P21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases (1998) Oncogene, 16, pp. 431-441
• Meijer, L., Chemical inhibitors of cyclin-dependent kinases (1996) Trends Cell Biol., 6, pp. 393-397
• Messina, M.J., Persky, V., Setchell, K.D.R., Barnes, S., Soy intake and cancer risk: A review of the in vitro and in vivo data (1994) Nutr. Cancer, 21, pp. 113-131
• Mishra, S., Hamburger, A.W., Exogenous phosphotyrosine modulates epidermal growth factor receptor tyrosine phosphorylation (1993) Carcinogenesis, 14, pp. 269-273
• Mizuno, K., Noda, K., Ueda, Y., Hanaki, H., Saido, T.C., Ikuta, T., Kuroki, T., Ohno, S., UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily (1995) FEBS Lett., 359, pp. 259-261
• Morinville, A., Naysinger, D., Shaver, A., From vanadis to atropos: Vanadium compounds as pharmacological tools in cell death signalling (1998) Trends Pharmacol. Sci., 19, pp. 452-460
• Motojima, K., Goto, S., Histidyl phosphorylation and dephosphorylation of P36 in rat liver extract (1994) J. Biol. Chem., 269, pp. 9030-9037
• Nakano, H., Kobayashi, E., Takahashi, I., Tamaoki, T., Kuzuu, Y., Iba, H., Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60 (1987) J. Antibiotics, 40, pp. 706-708
• Nasheuer, H.-P., Moore, A., Wahl, A.F., Wang, T.S.F., Cell cycle-dependent phosphorylation of human DNA polymerase alpha (1991) J. Biol. Chem., 266, pp. 7893-7903
• Niggli, V., Keller, H., On the role of protein kinases in regulating neutrophil actin association with the cytoeskeleton (1991) J. Biol. Chem., 266, pp. 7927-7932
• Okura, A., Arakawa, H., Hirofumi, O., Yoshinari, T., Monden, Y., Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cells (1988) Biochem. Biophys. Res. Commum., 157, pp. 183-189
• Onishi, Y., Azuma, Y., Kizaki, H., An assay method for DNA topoisomerase activity based on separation of relaxed DNA from supercoiled DNA using high-performance liquid chromatography (1993) Anal. Biochem., 210, pp. 63-68
• Pagano, M., Pepperkok, R., Lukas, J., Baldin, V., Ansorge, W., Bartek, J., Draetta, G., Regulation of the cell cycle by the cdk2 protein kinase in cultures human fibroblasts (1993) J. Cell. Biol., 121, pp. 101-111
• Pardee, A.B., G1 events and regulation of cell proliferation (1989) Science, 246, pp. 603-608
• Pardee, A.B., Coppock, D.L., Yang, H.C., Regulation of cell proliferation at the onset of DNA synthesis (1986) J. Cell. Sci. (Suppl.), 4, pp. 171-180
• Peterson, G., Barnes, D., Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene (1991) Biochem. Biophys. Res. Commun., 179, pp. 661-667
• Planas-Silva, M.D., Weinberg, R.A., The restriction point and control of cell proliferation (1997) Curr. Opin. Cell Biol., 9, pp. 768-772
• Rozengurt, E., Early signals in the mitogenic response (1986) Science, 234, pp. 161-166
• Salah-Ud-Din, Brill, S.J., Fairman, M.P., Stillman, B., Cell-cycle-regulated phosphorylation of DNA replication factor A from human and yeast cells (1997) Genes Dev., 4, pp. 968-977
• Sharma, R., Kleine, L.P., Franks, D.J., The epidermal growth factor mitogenic signal is modulated by protein kinases C in T51B rat liver cells (1994) Cell. Signal, 6, pp. 631-643
• Shields, R., Transition probability and the origin of variation in the cell cycle (1977) Nature, 267, pp. 704-707
• Shimokado, K., Umezawa, K., Ogata, J., Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells (1995) Exp. Cell Res., 220, pp. 266-273
• Simn, A., Hoppe, V., Karbach, D., Leicht, M., Fenn, A., Hoppe, J., Late signals from the PDGF receptors leading to the activation of the p70S6-kinase are necessary for the transition from G1 to S phase in AKR-2B cells (1998) Exp. Cell Res., 244, pp. 379-393
• Stillman, B., Cell cycle control of DNA replication (1996) Science, 274, pp. 1659-1664
• Swarup, G., Cohen, S., Garbers, D.L., Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate (1982) Biochem. Biophys. Res. Commun., 107, pp. 1104-1109
• Swarup, G., Speeg K.V., Jr., Cohen, S., Garbers, D.L., Phosphotyrosyl-protein phosphatase of TCRC-2 cells (1982) J. Biol. Chem., 257, pp. 7298-7301
• Tamaoki, T., Use and specificity of staurosporine, UCN-01, and calphostin-C as protein kinase inhibitors (1991) Methods Enzymol., 201, pp. 340-347
• Uehara, Y., Fukazawa, H., Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinase (1991) Methods Enzymol., 201, pp. 370-379
• Uehara, Y., Murakami, Y., Mizuno, S., Kawai, S., Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A (1988) Virology, 164, pp. 294-298
• Uehara, Y., Murakami, Y., Sugimoto, Y., Mizuno, S., Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: Reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src (1989) Cancer Res., 49, pp. 780-785
• Veeranna, S.K.T., Amin, N., Grant, P., Albers, R.W., Pant, H.C., Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogues is independent of activation by Munc-18 (1996) Neurochem. Res., 21, pp. 629-636
• Voytas, D., Resolution and recovery of DNA fragments (1991) Current Protocols in Immunology, pp. 1041-1048. , J. E. Coligan, D. H. Margulies, E. M. Shevach, & W. Strober. New York: Wiley
• Yakisich, J.S., Radrizzani, M., Idoyaga Vargas, V., Examination of the natural protein substrates affected by staurosporine in the developing cerebral cortex (1994) Neurosci. Lett., 180, pp. 17-20
• Yakisich, J.S., Sidén, Å., Idoyaga Vargas, V., Eneroth, P., Cruz, M., Fast and sensitive method for simultaneous measurement of cell proliferation rate and drug sensitivity in rat cerebral cortex (1998) Exp. Neurol., 151, pp. 194-202
• Zetterberg, A., Larsson, O., Coordination between cell growth and cell cycle transit in animal cells (1991) Cold Spring Harbor Symp. Quant. Biol., 56, pp. 137-147
• Zolfaghari, A., Djakiew, D., Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function (1996) Prostate, 28, pp. 232-238

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------